175 related articles for article (PubMed ID: 26682615)
1. Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy.
Simonetti FR; Ricaboni D; Cattaneo D; Micheli V; Rusconi S; Gervasoni C
J Clin Virol; 2016 Jan; 74():75-7. PubMed ID: 26682615
[TBL] [Abstract][Full Text] [Related]
2. HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?
Philibert P; Chiche L; Caillères S; Allemand J; Rebaudet S; Delord M; Stavris C; Retornaz F; Khiri H; Halfon P
AIDS; 2017 Sep; 31(15):2167-2169. PubMed ID: 28692546
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
4. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
[TBL] [Abstract][Full Text] [Related]
5. HHV-8 DNA in blood and the development of HIV-associated Kaposi's sarcoma in the era of HAART--a prospective evaluation.
Lorenzen T; Albrecht D; Paech V; Meyer T; Hoffmann C; Stoehr A; Degen O; Stellbrink HJ; Meigel WN; Arndt R; Plettenberg A
Eur J Med Res; 2002 Jun; 7(6):283-6. PubMed ID: 12117665
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients.
De Milito A; Catucci M; Venturi G; Romano L; Incandela L; Valensin PE; Zazzi M
J Med Virol; 1999 Feb; 57(2):140-4. PubMed ID: 9892398
[TBL] [Abstract][Full Text] [Related]
7. Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.
Tedeschi R; Enbom M; Bidoli E; Linde A; De Paoli P; Dillner J
J Clin Microbiol; 2001 Dec; 39(12):4269-73. PubMed ID: 11724831
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.
Gnann JW; Pellett PE; Jaffe HW
Clin Infect Dis; 2000 Apr; 30 Suppl 1():S72-6. PubMed ID: 10770915
[TBL] [Abstract][Full Text] [Related]
10. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
Leitch H; Trudeau M; Routy JP
HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
[TBL] [Abstract][Full Text] [Related]
11. Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.
Torre-Cisneros J; Pozo F; Serrano R; Vidal E; Rivero A; Tenorio A
AIDS; 2000 Sep; 14(14):2215-7. PubMed ID: 11061671
[No Abstract] [Full Text] [Related]
12. HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma.
Broccolo F; Tassan Din C; Viganò MG; Rutigliano T; Esposito S; Lusso P; Tambussi G; Malnati MS
J Clin Virol; 2016 May; 78():47-52. PubMed ID: 26985593
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
[TBL] [Abstract][Full Text] [Related]
14. Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
Núñez M; Saballs P; Valencia ME; Santos J; Ferrer E; Santos I; Berrocal A; Galindo MJ; Podzamczer D; Gonzlez-Lahoz J;
HIV Clin Trials; 2001; 2(5):429-37. PubMed ID: 11673818
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
[TBL] [Abstract][Full Text] [Related]
17. Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.
Gantt S; Cattamanchi A; Krantz E; Magaret A; Selke S; Kuntz SR; Huang ML; Corey L; Wald A; Casper C
J Clin Virol; 2014 Jun; 60(2):127-32. PubMed ID: 24698158
[TBL] [Abstract][Full Text] [Related]
18. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
[TBL] [Abstract][Full Text] [Related]
19. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.
Jacobson LP; Jenkins FJ; Springer G; Muñoz A; Shah KV; Phair J; Zhang Z; Armenian H
J Infect Dis; 2000 Jun; 181(6):1940-9. PubMed ID: 10837173
[TBL] [Abstract][Full Text] [Related]
20. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
